Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and PK of Omecamtiv Mecarbil in Ischemic Cardiomyopathy
NCT00682565Phase 2Completed
- Sponsor
- Cytokinetics
- Start
- Apr 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of omecamtiv mecarbil in ischemic cardiomyopathy (ICM), angina pectoris, sponsored by Cytokinetics. Started Apr 2008; status: completed.
02
Drugs
omecamtiv mecarbil
03
Conditions
ischemic cardiomyopathy (ICM)angina pectoris
Beyond the preview
Go deeper on NCT00682565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00682565.